Snap-8

Snap-8, catalogued as acetyl octapeptide-3, has the sequence Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2. Both termini are capped: an acetyl group on the N-terminus and an amide on the C-terminus, each removing a charge that the free peptide would otherwise carry and each adding a specific mass increment that identity work can confirm.

The sequence is an extended analogue of the N-terminal region of SNAP-25, one of the three proteins that assemble into the neuronal SNARE complex alongside syntaxin and synaptobrevin. The proposed mechanism is competitive: a free peptide resembling part of SNAP-25 interferes with incorporation of the full protein into the ternary complex that drives vesicle fusion. It is two residues longer than the related acetyl hexapeptide-8, and the literature attributes the measured difference between the two to that extension.

Cell-free SNARE assembly assays are the most direct system in this literature, measuring whether the peptide reduces formation of the SDS-resistant ternary complex that assembled SNARE proteins produce. Chromaffin cell preparations provide the standard cellular readout, since catecholamine release from these cells is SNARE dependent and quantifiable by amperometry.

Comparative work against the shorter hexapeptide analogue recurs throughout the literature, and the reported difference in potency between two closely related sequences is one of the more informative results for anyone characterising this chemical class. Reported activity is concentration dependent and, as with any competition-based mechanism, depends on the ratio of peptide to native protein in the system rather than on peptide concentration alone.

Methionine at position three is the residue that matters analytically. It oxidises to the sulfoxide, adding 16 daltons, and the oxidised form is resolvable both by mass spectrometry and as a distinct earlier-eluting peak on reversed-phase HPLC. A lot analysis that does not account for the methionine sulfoxide peak has not looked at the impurity most likely to be present.

Mass spectrometry confirms both terminal modifications directly, since acetylation adds 42 daltons and C-terminal amidation gives a mass one dalton below the corresponding free acid. The peptide carries two arginines against three acidic residues, so the counterion matters: material purified by standard reversed-phase methods is supplied as the trifluoroacetate salt unless an acetate exchange has been performed, and net peptide content differs from HPLC purity accordingly.